/ TerminatedNot Applicable Reproducibility and Method Comparison of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver of the Quo-Test™ A1C System
The Quo-Test A1C Analyzer and Reagent Test System (Quo-Test A1C System) are intended for the in-vitro quantitative determination of glycated hemoglobin in whole blood samples obtained from fingerstick or venous samples for point-of-care testing. The Quo-Test A1C System is indicated in the management and treatment of diabetes and for monitoring long term glycemic control by diabetics. It is for multiple patient use. Only auto-disabling, single use lancing devices should be used with this system.
100 Clinical Results associated with Quotient Diagnostics Ltd.
0 Patents (Medical) associated with Quotient Diagnostics Ltd.
100 Deals associated with Quotient Diagnostics Ltd.
100 Translational Medicine associated with Quotient Diagnostics Ltd.